Skip to main content

Advertisement

SpringerLink
Log in

New era for management of primary hypertensive intracerebral hemorrhage

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

This discussion focuses on recent reports relevant to improved understanding and future directions in the management of intracerebral hemorrhage (ICH). Prevention is possible with adequate treatment of hypertension; microbleeds, apolipoprotein genotype, and cholesterol treatment have been examined in relation to ICH risk. Hematoma products, matrix metalloproteinases, inflammatory markers, and means to attenuate injury have also received attention. The multifaceted character of perihematomal edema has been further defined but evidence for perihematomal ischemia remains elusive. New data on acute blood pressure reinforces the need for a clinical trial. With the lack of efficacy found in the International Surgical Trial in Intracerebral Hemorrhage (ISTICH), a landmark surgical trial, emphasis is shifting to minimally invasive and catheter/ thrombolytic-based technologies for clot evacuation. On the medical side, activated factor VII has been shown to control hemorrhage growth. Looking forward, stem cell therapies for ICH are under investigation and some outcome studies are shedding new rays of hope.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Ariesen MJ, Claus SP, Rinkel GJ, Algra A: Risk factors for intracerebral hemorrhage in the general population: a systemic review. Stroke 2003, 34:2060–2065.

    Article  PubMed  CAS  Google Scholar 

  2. Woo D, Kissela BM, Khoury JC, et al.: Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study. Stroke 2004, 35:1360–1364.

    Article  PubMed  CAS  Google Scholar 

  3. Woo D, Haverbusch M, Sekar P, et al.: Effect of untreated hypertension on hemorrhagic stroke. Stroke 2004, 35:1703–1708.

    Article  PubMed  Google Scholar 

  4. Blood Pressure Lowering Treatment Trialists’ Collaboration: Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectivelydesigned overviews of randomized trials. Lancet 2003, 362:1527–1535.

    Article  CAS  Google Scholar 

  5. McCarron MO, Weir CJ, Muir KW, et al.: Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral hemorrhage. Acta Neurol Scand 2003, 107:106–109. This is the first study to identify a genetic marker for ICH.

    Article  PubMed  CAS  Google Scholar 

  6. Naka H, Nomura E, Wakabayashi S, et al.: Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: association with combination of stroke subtypes and leukoaraiosis. Am J Neuroradiol 2004, 25:714–719.

    PubMed  Google Scholar 

  7. Fan YH, Zhang L, Lam WW, et al.: Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 2003, 34:2459–2462.

    Article  PubMed  Google Scholar 

  8. Greenberg SM, Eng JA, Ning M, et al.: Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004, 35:1415–1420.

    Article  PubMed  Google Scholar 

  9. Jeong SW, Jung KH, Chu K, et al.: Clinical and radiologic differences between primary intracerebral hemorrhage with and without microbleeds on gradient-echo magnetic resonance images. Arch Neurol 2004, 61:905–909.

    Article  PubMed  Google Scholar 

  10. Chalela JA, Kang DW, Warach S: Multiple cerebral microbleeds: MRI marker of a diffuse hemorrhage-prone state. J Neuroimaging 2004, 14:54–57.

    Article  PubMed  Google Scholar 

  11. Power C, Henry S, Del Biggio MR, et al.: Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol 2003, 53:731–742.

    Article  PubMed  CAS  Google Scholar 

  12. Lee JM, Yin KJ, Hsin I, et al.: Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy. Ann Neurol 2003, 54:379–382.

    Article  PubMed  CAS  Google Scholar 

  13. Abilleira S, Montaner J, Molina CA, et al.: Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg 2003, 99:65–70. This is a welcome attempt to translate experimental findings in laboratory stroke models to humans.

    Article  PubMed  CAS  Google Scholar 

  14. Alvarez-Sabin J, Delgado P, Albilleira S, et al.: Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiologic outcome. Stroke 2004, 35:1316–1322.

    Article  PubMed  CAS  Google Scholar 

  15. Qureshi AI, Suri MF, Ostrow PT, et al.: Apoptosis as a form of cell death in intracerebral hemorrhage. Neurosurgery 2003, 52:1041–1048.

    Article  PubMed  Google Scholar 

  16. Nakamura T, Xi G, Hua Y, et al.: Nestin expression after experiemental intracerebral hemorrhage. Brain Res 2003, 981:108–117.

    Article  PubMed  CAS  Google Scholar 

  17. Goldstein L, Teng ZP, Zeserson E, et al.: Hemin induces an iron-dependent, oxidative injury to human neuron-like cells. J Neurosci Res 2003, 73:113–121.

    Article  PubMed  CAS  Google Scholar 

  18. Jung KH, Chu K, Jeong SW, et al.: HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 2004, 35:1744–1749.

    Article  PubMed  CAS  Google Scholar 

  19. MacLellan CL, Girgis J, Colbourne F: Delayed onset of prolonged hypothermia improves outcome after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab 2004, 24:432–440.

    Article  PubMed  Google Scholar 

  20. Inaji M, Tmita H, Tone O, et al.: Chronological changes of perihematomal edema of human intracerebral hematoma. Acta Neurochir 2003, 86(Suppl):445–448.

    CAS  Google Scholar 

  21. Carhuapoma JR, Hanley DF, Banerjee M, Beauchamp NJ: Brain edema after human cerebral hemorrhage: a magnetic resonance imaging volumetric analysis. J Neurosurg Anesthesiol 2003, 15:230–233.

    Article  PubMed  Google Scholar 

  22. Butcher KS, Baird T, MacGregor L, et al.: Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke 2004, 35:1879–1885.

    Article  PubMed  Google Scholar 

  23. Gebel JM, Jauch EC, Brott TG, et al.: Relative edema is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002, 33:2636–2641.

    Article  PubMed  Google Scholar 

  24. Song EC, Chu K, Jeong SW, et al.: Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke 2003, 34:2215–2220.

    Article  PubMed  CAS  Google Scholar 

  25. Kitaoka T, Hua Y, Xi G, et al.: Effect of delayed argatroban treatment on intracerebral hemorrhage-induced edema in the rat. Acta Neurochir 2003, 86(Suppl):457–461.

    CAS  Google Scholar 

  26. Schellinger PD, Fiebach JB, Hoffmann K, et al.: Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke 2003, 34:1674–1679.

    Article  PubMed  Google Scholar 

  27. Ohwaki K, Yano E, Nagashima H, et al.: Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004, 35:1364–1367. This is the first study to identify a blood pressure threshold that may relate to the likelihood of further hemorrhage

    Article  PubMed  Google Scholar 

  28. Piriyawat P, Morgenstern LB, Yawn DH, et al.: Treatment of acute intracerebral hemorrhage with epsilon-aminocaproic acid: a pilot study. Neurocrit Care 2004, 1:47–52.

    Article  PubMed  CAS  Google Scholar 

  29. Mayer SA, Brun N, Broderick J, et al.: Recombinant factor VIIa for acute intracerebral hemorrhage. Paper presented at 5th World Stroke Congress, Vancouver, Canada, June 26, 2004. http:// www.prous.com/webcaster/WSC2004/. Accessed August 12, 2004. This is the first controlled study to show the benefit of any therapy for ICH, which is an exciting development for the entire stroke field.

  30. Mendelow AD; Investigators and the Steering Committee: The International Surgical Trial in Intracerebral Hemorrhage (ISTICH). Acta Neurochir 2003, 86(Suppl):441–443. This landmark study is the only adequately powered study to address the benefit of surgical clot evacuation. The study embodies a number of unique design features. Its results will change clinical practice.

    Google Scholar 

  31. Gregson BA, Mendelow AD; STICH investigators: International variations in surgical practice for spontaneous intracerebral hemorrhage. Stroke 2003, 34:2593–2597.

    Article  PubMed  Google Scholar 

  32. Marquardt G, Wolff R, Sager A, et al.: Subacute stereotactic aspiration of haematomas within the basal ganglia reduces occurrence of complications in the course of haemorrhagic stroke in non-comatose patients. Cerebrovasc Dis 2003, 15:252–257.

    Article  PubMed  Google Scholar 

  33. Lee JI, Nam do H, Kim JS, et al.: Stereotactic aspiration of intracerebral haematoma: significance of surgical timing and haematoma volume reduction. J Clin Neurosci 2003, 10:439–443.

    Article  PubMed  Google Scholar 

  34. Teernstra OP, Evers SM, Lodder J, et al.: Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 2003, 34:968–974.

    Article  PubMed  CAS  Google Scholar 

  35. Qiu Y, Lin Y, Tian X, Luo Q: Hypertensive intracranial hematomas: endoscopic-assisted keyhole evacuation and application of a patent viewing dissector. Chin Med J 2003, 116:195–199.

    PubMed  Google Scholar 

  36. Nakano T, Ohkuma H, Ebina K, Suzuki S: Neuroendoscopic surgery for intracerebral hemorrhage-comparison with traditional therapies. Min Invasive Neurosurg 2003, 46:278–283.

    Article  CAS  Google Scholar 

  37. Naff N, Hanley DF, Keyl P, et al.: Intraventricular urokinase speeds clot resolution: results of a pilot, prospective, randomized, double blind, controlled trial. Neurosurgery 2004, 54:577–583. This is a labor-intensive clinical trial that demonstrates the safety and benefit of an aggressive approach to clot removal after IVH. It will give a boost to minimally invasive stereotactic and endoscopic approaches to ICH as well as IVH.

    Article  PubMed  Google Scholar 

  38. Lee MW, Pang KY, Ho W, Wong CK: Outcome analysis of intraventricular thrombolytic therapy for intraventricular hemorrhage. Hong Kong Med J 2003, 9:335–340.

    PubMed  CAS  Google Scholar 

  39. Longatti PL, Martinuzzi A, Fiorindi A, et al.: Neuroendosopic management of intraventricular hemorrhage. Stroke 2004, 35:35–38.

    Article  Google Scholar 

  40. Jeong SW, Chu K, Jung KH, et al.: Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 2003, 34:2258–2263.

    Article  PubMed  Google Scholar 

  41. Nonaka M, Yoshikawa M, Nishimura F, et al.: Intraventricular transplantation of embryonic stem cell-derived neural stem cells in intracerebral hemorrhage rats. Neurol Res 2004, 26:265–272.

    Article  PubMed  Google Scholar 

  42. Paolucci S, Antonucci G, Grasso MG, et al.: Functional outcome of ischemic and hemorrhagic stroke patients after inpatient rehabilitation: a matched comparison. Stroke 2003, 34:2861–2865.

    Article  PubMed  Google Scholar 

  43. Wessels T, Moller-Hartmann W, Noth J, Klotzsch C: CT findings and clinical features as markers for patient outcome in primary pontine hemorrhage. Am J Neuroradiol 2004, 25:257–260.

    PubMed  Google Scholar 

  44. Roch A, Michelet P, Jullien AC, et al.: Long-term outcome in intensive care unit survivors after mechanical ventilation for intracerebral hemorrhage. Crit Care Med 2003, 31:2651–2656.

    Article  PubMed  Google Scholar 

  45. Hemphill JC, Newman J, Zhao S, Johnston SC: Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke 2004, 35:1130–1134.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Texas Houston Medical School, 6431 Fannin Street, 77030, Houston, TX, USA

    Christiana E. Hall MD & James C. Grotta MD

Authors
  1. Christiana E. Hall MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James C. Grotta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hall, C.E., Grotta, J.C. New era for management of primary hypertensive intracerebral hemorrhage. Curr Neurol Neurosci Rep 5, 29–35 (2005). https://doi.org/10.1007/s11910-005-0020-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-005-0020-5

Keywords

Search

Navigation